Publication | Open Access

Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting

ThrombosisCardiac AnaesthesiaCardiovascular DiseasePerioperative UseTirofiban HydrochloridePerioperative CareAnticoagulantSurgeryPlatelet AntagonistMedicineSurgical BleedingCardiologyEmergency MedicineAnesthesiology